Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-20 Sale | 2024-02-22 4:30 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 3,967 | $7.5019 | $29,760 | 87,627 (Direct) | View |
| 2024-01-17 Sale | 2024-01-19 4:32 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 1,266 | $7.18 | $9,090 | 53,094 (Direct) | View |
| 2023-09-15 Sale | 2023-09-18 4:44 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 10,500 | $8.16 | $85,680 | 94,360 (Direct) | View |
| 2023-07-06 Sale | 2023-07-10 4:42 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,500 | $10.8 | $59,400 | 59,860 (Direct) | View |
| 2023-06-30 Sale | 2023-07-05 4:32 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $11.41 | $57,050 | 110,360 (Direct) | View |
| 2023-03-20 Sale | 2023-03-22 4:49 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 2,193 | $7.76 | $17,018 | 65,360 (Direct) | View |
| 2023-02-17 Sale | 2023-02-22 8:57 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 738 | $7.45 | $5,498 | 135,553 (Direct) | View |
| 2023-02-13 Sale | 2023-02-15 4:53 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 797 | $7.67 | $6,113 | 34,291 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:55 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 1,106 | $9.8485 | $10,892 | 35,088 (Direct) | View |
| 2023-01-06 Sale | 2023-01-10 4:07 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 388 | $6.41 | $2,487 | 36,194 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-09 Option Award | 2024-02-16 5:04 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 115,500 | $0 | 168,594 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-18 4:44 pm | N/A 2032-01-13 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $0 | 94,360 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-18 4:44 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $2.85 | 94,360 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-05 4:32 pm | N/A 2032-01-13 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $0 | 110,360 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-05 4:32 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $2.85 | 110,360 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 8:57 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 102,000 | $0 | 135,553 (Direct) | View |
| 2022-12-31 Option Award | 2023-01-10 4:07 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 388 | $5.17 | 36,194 (Direct) | View |
| 2022-09-19 Option Award | 2022-09-21 4:42 pm | N/A 2032-09-19 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 165,000 | $0 | 165,000 (Direct) | View |
Ownership | 2022-09-21 4:39 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 0 | $0 | 210,120 (Direct) | View |